Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

13 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251113825408/en/Neurogene-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Updates

12 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251112150450/en/Neurogene-Reports-Positive-Interim-Data-in-Pediatric-Cohort-from-NGN-401-Gene-Therapy-Trial-for-Rett-Syndrome

06 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251106135659/en/Neurogene-Announces-First-Participant-Dosed-in-Embolden-Registrational-Trial-of-NGN-401-Gene-Therapy-for-Rett-Syndrome

05 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251105674125/en/Neurogene-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

09 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251009995946/en/Neurogene-Announces-Positive-Regulatory-Update-for-NGN-401-Gene-Therapy-in-Rett-Syndrome-with-Plans-to-Initiate-Dosing-in-Embolden-Registrational-Trial-in-Q4-2025

08 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251008682068/en/Neurogene-to-Participate-in-H.C.-Wainwright-Genetic-Medicines-Virtual-Conference
ABOUT THIS PAGE